Does the development of new medicinal products in the European Union address global and regional health concerns?

BACKGROUND: Since 1995, approval for many new medicinal products has been obtained through a centralized procedure in the European Union. In recent years, the use of summary measures of population health has become widespread. We investigated whether efforts to develop innovative medicines are focus...

Descripción completa

Detalles Bibliográficos
Autores principales: Catalá-López,, Ferrán, García-Altés,, Anna, Álvarez-Martín, Elena, Gènova-Maleras, Ricard, Morant-Ginestar, Consuelo
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3017015/
https://www.ncbi.nlm.nih.gov/pubmed/21172012
http://dx.doi.org/10.1186/1478-7954-8-34

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3017015/
https://www.ncbi.nlm.nih.gov/pubmed/21172012
http://dx.doi.org/10.1186/1478-7954-8-34

Ejemplares similares